Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

MAZE vs REPL: stock comparison and AI forecast

Maze Therapeutics, Inc. (MAZE) and Replimune Group, Inc. (REPL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Biological Products, (No Diagnostic Substances)

MAZE Maze Therapeutics, Inc.

Price
$33.38 +26.1% · 6M
Market Cap
$1.81B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Biological Products, (No Diagnostic Substances)

REPL Replimune Group, Inc.

Market Cap
$1.96B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

MAZE · REPL

Key facts

  • MAZE and REPL have similar market capitalizations ($1.81B and $1.96B).
  • REPL carries 0.83 times debt per unit of equity, against 0.17 times for MAZE.
  • Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricMAZEREPL
Market Cap$1.81B$1.96B
P/B Ratio3.99x9.58x
EPS$-1.89$-3.02
Book Value/Share$8.16$2.16
FCF/Share$-1.92$-2.56

Profitability & Margins

MetricMAZEREPL
ROE-29.5%-132.4%
ROA-25.1%-72.5%
ROIC-28.6%-82.1%
Operating Margin-364.0%–
Net Margin-334.0%–
EBT Margin-281.7%–
Tax Rate–0.2%

Financial Health

MetricMAZEREPL
Current Ratio18.31x7.11x
Quick Ratio–6.90x
D/E Ratio0.17x0.83x
Financial Leverage1.17x1.83x
Interest Coverage–-22.3x
Working Capital$397M$278M

Cash Flow

MetricMAZEREPL
Operating Cash Flow-$107M-$246M
Free Cash Flow-$107M-$243M
Capital Spending-$300K$3M

Income Statement

MetricMAZEREPL
Operating Income-$146M-$270M
Net Income-$134M-$271M
R&D Expense$122M$189M

Dividend & Shareholder Information

MetricMAZEREPL
Shares Outstanding56M95M
FAQ

MAZE vs REPL: stock comparison and AI forecast

Which is bigger, MAZE or REPL?

MAZE and REPL have similar market capitalizations ($1.81B and $1.96B).

Which one does Intratio's AI model rank higher, MAZE or REPL?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.